Dali Mu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dali Mu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
Yan Lin
Department of Breast Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
31 shared publicationsHaoran Li
Affiliation Department of Breast Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
25 shared publicationsXiaoyu Zhang
Department of Aesthetic and Reconstructive Breast Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 33 Badachu Road, Shijingshan District, Beijing, 100144, People's Republic of China
21 shared publicationsYan Yang
Department of Burns and Plastic Surgery, Xiangya Hospital, Central South University, Changsha, People’s Republic of China
9 shared publicationsTongtong Zhang
Department of Breast Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and, Peking Union Medical College, Beijing, People’s Republic of China
8 shared publicationsZhengyao Li
Affiliation Department of Breast Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
8 shared publications
Latest Publications
- 30 October 2026
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 158 (5) , 905e-906e
Reply: Serratus Anterior Plane Block with Methylene Blue and Ropivacaine for Analgesia in Prosthetic Breast Augmentation: A Randomized Controlled Trial
Was not provided for this article.
- 30 October 2026
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 158 (5) , 905e-906e
Reply: Serratus Anterior Plane Block with Methylene Blue and Ropivacaine for Analgesia in Prosthetic Breast Augmentation: A Randomized Controlled Trial
Was not provided for this article.
- Open Access
- 4 January 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Biomimetic “Tendon Band-Aid” regulates inflammatory microenvironment and tenogenic differentiation for tendinopathy regeneration
Tendinopathy (TDP) is a common yet challenging chronic degenerative condition characterized by disrupted inflammatory microenvironments, cellular dysfuncti
- 4 January 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessBiomimetic “Tendon Band-Aid” regulates inflammatory microenvironment and tenogenic differentiation for tendinopathy regeneration
Tendinopathy (TDP) is a common yet challenging chronic degenerative condition characterized by disrupted inflammatory microenvironments, cellular dysfuncti
- Open Access
- 1 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0335152
Integrated single-cell RNA-seq and bulk RNA-seq analysis to investigate key adipogenesis genes in adipose-derived stem cells
Adipogenic differentiation of adipose-derived stem cells (ADSCs) is fundamental to both adipose tissue homeostasis and clinical applications, particularly fat grafting. However, the global and stage-specific transcriptional regulatory networks underlying ADSC adipogenesis remain incompletely elucidated. In this study, we integrated bulk and single-cell RNA-seq datasets across multiple time points of ADSC adipogenesis to identify core regulators of differentiation and maturation. A total of 41 genes were consistently upregulated during early differentiation, among which eight hub genes (FABP4, FASN, FABP5, ADIPOQ, PLIN1, LPL, CIDEC, and ACSL1) formed a tightly connected protein–protein interaction (PPI) module associated with lipid metabolism, lipid droplet formation, and adipocyte maturation. Further integration of differentially expressed lncRNAs and miRNAs led to the construction of a ceRNA network involving 7 mRNAs, 9 miRNAs, and 4 lncRNAs, comprising 34 predicted lncRNA–miRNA–mRNA regulatory axes. To identify temporal transcriptional regulators, we defined five genes (TTC14, MBNL2, UBR3, ABCD2, and SORT1) as early-stage inducers of adipogenesis, and four genes (UQCR11, NDUFB4, S100A10, and PRDX3) as late-stage regulators involved in maintaining the mature phenotype. These stage-specific regulators showed distinct temporal expression patterns and were validated by qPCR. GeneMANIA network analysis further revealed that early-stage regulators were enriched in lipid transport and lipase activity regulation, while late-stage regulators were associated with mitochondrial electron transport and energy metabolism. These findings highlight the stage-dependent transcriptional landscape of ADSC adipogenesis and provide candidate regulatory targets for modulating adipocyte differentiation and stability.
- 1 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0335152
Open AccessIntegrated single-cell RNA-seq and bulk RNA-seq analysis to investigate key adipogenesis genes in adipose-derived stem cells
Adipogenic differentiation of adipose-derived stem cells (ADSCs) is fundamental to both adipose tissue homeostasis and clinical applications, particularly fat grafting. However, the global and stage-specific transcriptional regulatory networks underlying ADSC adipogenesis remain incompletely elucidated. In this study, we integrated bulk and single-cell RNA-seq datasets across multiple time points of ADSC adipogenesis to identify core regulators of differentiation and maturation. A total of 41 genes were consistently upregulated during early differentiation, among which eight hub genes (FABP4, FASN, FABP5, ADIPOQ, PLIN1, LPL, CIDEC, and ACSL1) formed a tightly connected protein–protein interaction (PPI) module associated with lipid metabolism, lipid droplet formation, and adipocyte maturation. Further integration of differentially expressed lncRNAs and miRNAs led to the construction of a ceRNA network involving 7 mRNAs, 9 miRNAs, and 4 lncRNAs, comprising 34 predicted lncRNA–miRNA–mRNA regulatory axes. To identify temporal transcriptional regulators, we defined five genes (TTC14, MBNL2, UBR3, ABCD2, and SORT1) as early-stage inducers of adipogenesis, and four genes (UQCR11, NDUFB4, S100A10, and PRDX3) as late-stage regulators involved in maintaining the mature phenotype. These stage-specific regulators showed distinct temporal expression patterns and were validated by qPCR. GeneMANIA network analysis further revealed that early-stage regulators were enriched in lipid transport and lipase activity regulation, while late-stage regulators were associated with mitochondrial electron transport and energy metabolism. These findings highlight the stage-dependent transcriptional landscape of ADSC adipogenesis and provide candidate regulatory targets for modulating adipocyte differentiation and stability.
- 29 July 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 157 (3) , 452-462
Serratus Anterior Plane Block with Methylene Blue and Ropivacaine for Analgesia in Prosthetic Breast Augmentation: A Randomized Controlled Trial
Background: Pain is a prominent symptom following prosthetic breast augmentation by means of axillary incision, and persists throughout hospitalization. However, routine analgesia is not always effective for all patients. Duration of regional block with ropivacaine is also limited. The objective of this study was to evaluate whether the combination of methylene blue and ropivacaine by means of serratus anterior plane block provides superior long-lasting analgesia compared with ropivacaine alone in prosthetic breast augmentation. Methods: This double-blind, single-center, randomized controlled trial enrolled 72 female patients, who were randomly and equally assigned to the control group, the ropivacaine group, and the ropivacaine plus methylene blue group during surgery. A standard postoperative analgesic regimen was administered to all patients. The visual analog scale was used to assess pain scores, which were observed and recorded at 6, 24, 48, and 72 hours postoperatively by 2 well-trained, independent investigators. Results: No statistically significant differences were observed in age ( P = 0.200), body mass index ( P = 0.200), prosthesis brand ( P = 0.764), size ( P = 0.580), or type ( P = 0.260) among the 3 groups. The study demonstrated that serratus anterior plane block significantly improved postoperative pain management within 24 hours. Furthermore, the ropivacaine plus methylene blue group showed no advantages over the ropivacaine group at 6 hours postoperatively, whereas it had a better visual analog scale score than the ropivacaine group 24, 48, and 72 hours postoperatively, which were statistically significant differences ( P < 0.05). Conclusion: The analgesic effect of methylene blue and ropivacaine in serratus anterior plane block has a longer duration than ropivacaine alone in prosthetic breast augmentation.
- 29 July 2025
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 157 (3) , 452-462
Serratus Anterior Plane Block with Methylene Blue and Ropivacaine for Analgesia in Prosthetic Breast Augmentation: A Randomized Controlled Trial
Background: Pain is a prominent symptom following prosthetic breast augmentation by means of axillary incision, and persists throughout hospitalization. However, routine analgesia is not always effective for all patients. Duration of regional block with ropivacaine is also limited. The objective of this study was to evaluate whether the combination of methylene blue and ropivacaine by means of serratus anterior plane block provides superior long-lasting analgesia compared with ropivacaine alone in prosthetic breast augmentation. Methods: This double-blind, single-center, randomized controlled trial enrolled 72 female patients, who were randomly and equally assigned to the control group, the ropivacaine group, and the ropivacaine plus methylene blue group during surgery. A standard postoperative analgesic regimen was administered to all patients. The visual analog scale was used to assess pain scores, which were observed and recorded at 6, 24, 48, and 72 hours postoperatively by 2 well-trained, independent investigators. Results: No statistically significant differences were observed in age ( P = 0.200), body mass index ( P = 0.200), prosthesis brand ( P = 0.764), size ( P = 0.580), or type ( P = 0.260) among the 3 groups. The study demonstrated that serratus anterior plane block significantly improved postoperative pain management within 24 hours. Furthermore, the ropivacaine plus methylene blue group showed no advantages over the ropivacaine group at 6 hours postoperatively, whereas it had a better visual analog scale score than the ropivacaine group 24, 48, and 72 hours postoperatively, which were statistically significant differences ( P < 0.05). Conclusion: The analgesic effect of methylene blue and ropivacaine in serratus anterior plane block has a longer duration than ropivacaine alone in prosthetic breast augmentation.
- 7 February 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (14) , 4006-4012
A Predictive Model for Breast Tissue Resection Weight in Vertical-Scar Reduction Mammoplasty
Background Breast reduction surgery is currently the most critical treatment for macromastia. Preoperatively, patients are not only concerned about the surgical outcomes and potential complications but also about the amount of breast tissue that can be resected. Previous studies have proposed formulas to predict the amount of resected breast tissue; however, these studies often suffer from limited variables and small sample sizes, leading to less accurate predictions. Therefore, this study aims to develop a more accurate predictive model for breast tissue resection in breast reduction surgery by incorporating a greater number of variables, providing better clinical guidance. Methods Retrospective data from 360 patients (711 sides) who underwent vertical-scar reduction mammoplasty were collected. The data included preoperative patient information such as age, height, weight, BMI, and breast surface measurements, along with the accurately measured weight of breast tissue resected from each side during surgery. Statistical analysis was performed on the data, and multiple linear regression was used to determine the relationship between these variables and the weight of the resected breast tissue. Results The formula established is as follows: Breast tissue resection weight (g) = (15 × Sternal Notch-to-Nipple + 10 × Clavicle-to-Nipple + 23 × Nipple-to-Inframammary Fold + 10 × BMI + 6 × Inter-Nipple distance + 8 × Midline-to-Nipple)−1023. Conclusions This predictive model for breast tissue resection weight in vertical-scar reduction mammoplasty represents an empirical summary of clinical data. Implementing this model can aid surgeons in preoperatively estimating resection weight, ultimately improving surgical outcomes and increasing patient satisfaction. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 7 February 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (14) , 4006-4012
A Predictive Model for Breast Tissue Resection Weight in Vertical-Scar Reduction Mammoplasty
Background Breast reduction surgery is currently the most critical treatment for macromastia. Preoperatively, patients are not only concerned about the surgical outcomes and potential complications but also about the amount of breast tissue that can be resected. Previous studies have proposed formulas to predict the amount of resected breast tissue; however, these studies often suffer from limited variables and small sample sizes, leading to less accurate predictions. Therefore, this study aims to develop a more accurate predictive model for breast tissue resection in breast reduction surgery by incorporating a greater number of variables, providing better clinical guidance. Methods Retrospective data from 360 patients (711 sides) who underwent vertical-scar reduction mammoplasty were collected. The data included preoperative patient information such as age, height, weight, BMI, and breast surface measurements, along with the accurately measured weight of breast tissue resected from each side during surgery. Statistical analysis was performed on the data, and multiple linear regression was used to determine the relationship between these variables and the weight of the resected breast tissue. Results The formula established is as follows: Breast tissue resection weight (g) = (15 × Sternal Notch-to-Nipple + 10 × Clavicle-to-Nipple + 23 × Nipple-to-Inframammary Fold + 10 × BMI + 6 × Inter-Nipple distance + 8 × Midline-to-Nipple)−1023. Conclusions This predictive model for breast tissue resection weight in vertical-scar reduction mammoplasty represents an empirical summary of clinical data. Implementing this model can aid surgeons in preoperatively estimating resection weight, ultimately improving surgical outcomes and increasing patient satisfaction. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 4 January 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 228, 281-298
Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway
- 4 January 2025
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 228, 281-298
Enhancing fat graft survival: thymosin beta-4 facilitates mitochondrial transfer from ADSCs via tunneling nanotubes by upregulating the Rac/F-actin pathway
- 30 September 2024
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (1) , 339-344
The Mitochondrial Transplantation: A New Frontier in Plastic Surgery
Challenges such as difficult wound healing, ischemic necrosis of skin flaps, and skin aging are prevalent in plastic surgery. Previous research has indeed suggested that these challenges in plastic surgery are often linked to cellular energy barriers. As the powerhouses of the cell, mitochondria play a critical role in sustaining cellular vitality and health. Fundamentally, issues like ischemic and hypoxic damage to organs and tissues, as well as aging, stem from mitochondrial dysfunction, which leads to a depletion of cellular energy. Hence, having an adequate number of high-quality, healthy mitochondria is vital for maintaining tissue stability and cell survival. In recent years, there has been preliminary exploration into the protective effects of mitochondrial transplantation against cellular damage in systems such as the nervous, cardiovascular, and respiratory systems. For plastic surgery, mitochondrial transplantation is an extremely advanced research topic. This review focuses on the novel applications and future prospects of mitochondrial transplantation in plastic surgery, providing insights for clinicians and researchers, and offering guidance to patients seeking innovative and effective treatment options.
- 30 September 2024
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (1) , 339-344
The Mitochondrial Transplantation: A New Frontier in Plastic Surgery
Challenges such as difficult wound healing, ischemic necrosis of skin flaps, and skin aging are prevalent in plastic surgery. Previous research has indeed suggested that these challenges in plastic surgery are often linked to cellular energy barriers. As the powerhouses of the cell, mitochondria play a critical role in sustaining cellular vitality and health. Fundamentally, issues like ischemic and hypoxic damage to organs and tissues, as well as aging, stem from mitochondrial dysfunction, which leads to a depletion of cellular energy. Hence, having an adequate number of high-quality, healthy mitochondria is vital for maintaining tissue stability and cell survival. In recent years, there has been preliminary exploration into the protective effects of mitochondrial transplantation against cellular damage in systems such as the nervous, cardiovascular, and respiratory systems. For plastic surgery, mitochondrial transplantation is an extremely advanced research topic. This review focuses on the novel applications and future prospects of mitochondrial transplantation in plastic surgery, providing insights for clinicians and researchers, and offering guidance to patients seeking innovative and effective treatment options.
- Open Access
- 27 September 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-11
The effect of exogenous mitochondria in enhancing the survival and volume retention of transplanted fat tissue in a nude mice model
Despite the pivotal role of fat grafting in plastic, reconstructive, and aesthetic surgery, inconsistent survival rates of transplanted adipose tissue, primarily due to early ischemic and hypoxic insults, remain a significant challenge. The infusion of healthy mitochondria has emerged as a promising intervention to support tissue recovery from ischemic, hypoxic, and other types of damages across various organ systems. This study aims to evaluate the impact of supplementing human adipose tissue grafts with healthy exogenous mitochondria on their volume and mass retention rates when transplanted into the subcutaneous layers of nude mice. This approach seeks to improve and optimize fat grafting techniques. Human adipose tissues were preconditioned with exogenous mitochondria (10 µg/mL), a combination of exogenous mitochondria and the inhibitor Dyngo-4a, Dyngo-4a alone, or PBS, and then transplanted into the subcutaneous tissue of 24 nude mice. Samples were harvested at 1 and 3 months post-transplantation for analysis of mass and volume retention. The structural morphology and integrity of the adipose tissues were assessed using Hematoxylin and Eosin (H&E) staining. Mitochondrial preconditioning significantly enhanced the retention of mass and volume in fat grafts, demonstrating superior structural morphology and integrity compared to the control group. This study highlights the potential of exogenous mitochondrial augmentation in fat transplantation to significantly improve fat graft survival, thereby optimizing the success of fat grafting procedures.
- 27 September 2024
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 15 (1) , 1-11
Open AccessThe effect of exogenous mitochondria in enhancing the survival and volume retention of transplanted fat tissue in a nude mice model
Despite the pivotal role of fat grafting in plastic, reconstructive, and aesthetic surgery, inconsistent survival rates of transplanted adipose tissue, primarily due to early ischemic and hypoxic insults, remain a significant challenge. The infusion of healthy mitochondria has emerged as a promising intervention to support tissue recovery from ischemic, hypoxic, and other types of damages across various organ systems. This study aims to evaluate the impact of supplementing human adipose tissue grafts with healthy exogenous mitochondria on their volume and mass retention rates when transplanted into the subcutaneous layers of nude mice. This approach seeks to improve and optimize fat grafting techniques. Human adipose tissues were preconditioned with exogenous mitochondria (10 µg/mL), a combination of exogenous mitochondria and the inhibitor Dyngo-4a, Dyngo-4a alone, or PBS, and then transplanted into the subcutaneous tissue of 24 nude mice. Samples were harvested at 1 and 3 months post-transplantation for analysis of mass and volume retention. The structural morphology and integrity of the adipose tissues were assessed using Hematoxylin and Eosin (H&E) staining. Mitochondrial preconditioning significantly enhanced the retention of mass and volume in fat grafts, demonstrating superior structural morphology and integrity compared to the control group. This study highlights the potential of exogenous mitochondrial augmentation in fat transplantation to significantly improve fat graft survival, thereby optimizing the success of fat grafting procedures.
- 3 September 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (3) , 727-732
Principle and Logic of Vertical Reduction Repair Double-Ring Breast Reduction
Background Secondary reduction mammaplasty poses challenges. Objectives This article delves into the reasons and complaints regarding secondary repair following double-ring method and outlines the principle and logic of utilizing vertical incision for repair. Methods A retrospective analysis of patients who underwent secondary reduction mammaplasty in our hospital was conducted. The analysis included baseline demographic data, reasons for consultation, surgical records, and postoperative outcomes. Results Thirty-five patients (70 breasts) underwent secondary reduction mammaplasty. The mean time between the primary reduction mammaplasty and second procedure was 2.99 years (range, 0.5–15years). The mean weights were 210.49g (range, 42–558g) and 207.91g (range, 6–560g) for left and right mastectomies, respectively. Reasons for secondary reduction mammaplasty include poor shape (flat breasts and pseudoptosis), widened incision scar, persistent macromastia, and bilateral asymmetry. Conclusions The superior and superomedial vertical techniques are safe, effective, and satisfactory in secondary reduction mammaplasty. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 3 September 2024
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 49 (3) , 727-732
Principle and Logic of Vertical Reduction Repair Double-Ring Breast Reduction
Background Secondary reduction mammaplasty poses challenges. Objectives This article delves into the reasons and complaints regarding secondary repair following double-ring method and outlines the principle and logic of utilizing vertical incision for repair. Methods A retrospective analysis of patients who underwent secondary reduction mammaplasty in our hospital was conducted. The analysis included baseline demographic data, reasons for consultation, surgical records, and postoperative outcomes. Results Thirty-five patients (70 breasts) underwent secondary reduction mammaplasty. The mean time between the primary reduction mammaplasty and second procedure was 2.99 years (range, 0.5–15years). The mean weights were 210.49g (range, 42–558g) and 207.91g (range, 6–560g) for left and right mastectomies, respectively. Reasons for secondary reduction mammaplasty include poor shape (flat breasts and pseudoptosis), widened incision scar, persistent macromastia, and bilateral asymmetry. Conclusions The superior and superomedial vertical techniques are safe, effective, and satisfactory in secondary reduction mammaplasty. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 11 July 2024
- Published by Springer Nature in Research Square
The Role of Exogenous Mitochondria in Enhancing the Survival of Transplanted Fat Tissue
Background Despite the pivotal role of fat grafting in the realms of plastic, reconstructive, and aesthetic surgery, the erratic survival rates of transplanted adipose tissue, primarily due to early ischemic and hypoxic insults, pose a substantial challenge. The strategic infusion of healthy mitochondria has emerged as a critical intervention for the recuperation of tissues from ischemic, hypoxic, and a variety of damages across numerous organ systems. Objectives This investigation seeks to assess the impact of supplementing human adipose tissue grafts with healthy exogenous mitochondria on their volume and mass retention rates when transplanted into the subcutaneous layers of nude mice. This novel approach aims to refine and enhance the efficacy of fat grafting techniques. Methods Human adipose tissues were preconditioned with exogenous mitochondria (10µg/mL), a combination of exogenous mitochondria and the inhibitor Dyngo-4a, Dyngo-4a alone, and PBS, and subsequently transplanted into the subcutaneous tissue of 24 nude mice. Samples were harvested at 1 and 3 months post-transplantation for analysis of mass and volume retention. The structural morphology and integrity of the adipose tissues were evaluated using Hematoxylin and Eosin (H&E) staining. Results The incorporation of mitochondrial preconditioning significantly enhanced the retention of mass and volume in fat grafts, demonstrating superior structural morphology and integrity in comparison to those observed in the control group. Conclusions The outcomes of this study underscore the significant potential of exogenous mitochondrial augmentation in fat transplantation to substantially increase fat graft survival and, consequently, optimize the success rates of fat grafting interventions.
- 11 July 2024
- Published by Springer Nature in Research Square
Open AccessThe Role of Exogenous Mitochondria in Enhancing the Survival of Transplanted Fat Tissue
Background Despite the pivotal role of fat grafting in the realms of plastic, reconstructive, and aesthetic surgery, the erratic survival rates of transplanted adipose tissue, primarily due to early ischemic and hypoxic insults, pose a substantial challenge. The strategic infusion of healthy mitochondria has emerged as a critical intervention for the recuperation of tissues from ischemic, hypoxic, and a variety of damages across numerous organ systems. Objectives This investigation seeks to assess the impact of supplementing human adipose tissue grafts with healthy exogenous mitochondria on their volume and mass retention rates when transplanted into the subcutaneous layers of nude mice. This novel approach aims to refine and enhance the efficacy of fat grafting techniques. Methods Human adipose tissues were preconditioned with exogenous mitochondria (10µg/mL), a combination of exogenous mitochondria and the inhibitor Dyngo-4a, Dyngo-4a alone, and PBS, and subsequently transplanted into the subcutaneous tissue of 24 nude mice. Samples were harvested at 1 and 3 months post-transplantation for analysis of mass and volume retention. The structural morphology and integrity of the adipose tissues were evaluated using Hematoxylin and Eosin (H&E) staining. Results The incorporation of mitochondrial preconditioning significantly enhanced the retention of mass and volume in fat grafts, demonstrating superior structural morphology and integrity in comparison to those observed in the control group. Conclusions The outcomes of this study underscore the significant potential of exogenous mitochondrial augmentation in fat transplantation to substantially increase fat graft survival and, consequently, optimize the success rates of fat grafting interventions.